NCT01761019View on ClinicalTrials.gov

A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Psoriasis
Interventions
DRUG

Taclonex Topical Suspension

topical medication for psoriasis

Trial Locations (1)

15213

UPMC Department of Dermatology, Falk Clinic, Pittsburgh

Sponsors

Collaborators (1)

LEO Pharma
All Listed Sponsors
collaborator

LEO Pharma

INDUSTRY

lead

University of Pittsburgh

OTHER